Stason Pharmaceuticals, Inc

FDA inspection history in Irvine, California, 2016 to 2021

3
Form 483s
2
Close-outs

Every document, by year

  • Close-out
  • Form 483

2016: one Form 483; 2019: one Form 483; 2020: one close-out letter; 2021: one close-out letter and one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2016One Form 483, at Irvine, California.
  2. 2019–21Two Form 483s and two close-out letters, at Irvine, California.
  3. 2019The longest 483 on file: 15 observations over 11 pages at Irvine, California.

Cited most

Across all Stason Pharmaceuticals observations on file

The complete Stason Pharmaceuticals file.

All 5 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$421$495

15% off buying them one by one

Sites

Documents

5 on file, newest first
DateDocumentPrice
2021-06-24Close-out Close-out letter$99
2021-04-13483 Form 483$99
2020-07-08Close-out Close-out letter$99
2019-10-25483 Form 483$99
2016-03-08483 Form 483$99

FEI number 1000160561 · most recent document Jun 24, 2021

About Stason Pharmaceuticals, Inc

How many FDA Form 483s has Stason Pharmaceuticals, Inc received?

FDA Intel has 3 Form 483s on file for Stason Pharmaceuticals, Inc; the most recent is dated Apr 13, 2021.

When was Stason Pharmaceuticals, Inc last inspected by FDA?

The most recent FDA inspection document on file for Stason Pharmaceuticals, Inc is a Form 483 dated Apr 13, 2021, for the site in Irvine, California.

What did FDA cite at Stason Pharmaceuticals, Inc?

The regulations cited most in the observations on file for Stason Pharmaceuticals, Inc are 21 CFR 211.68 (Automatic, mechanical, and electronic equipment), 4 times; 21 CFR 211.192 (Production record review), 3 times; 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 2 times.